Oral News and Research

RSS

Radiotherapy: First choice treatment for low-grade glioma

In a large, international, randomized trial, initial radiotherapy was compared to temozolomide chemotherapy. A statistically significant difference between the two treatment strategies was not observed for progression-free survival, although radiotherapy was numerically favored. However, molecular tumor characterization may allow the treatment approach to be personalized and one or the other treatment modality to be selected.

30 May 2013

New article reports on global burden of oral conditions

Today, the International and American Associations for Dental Research published a paper titled "Global Burden of Oral Conditions in 1990-2010: A Systemic Analysis." The paper, written by lead author Wagner Marcenes, Queen Mary University, London, is published in the IADR/AADR Journal of Dental Research.

30 May 2013

Atopix awarded grant to pursue development of OC459 for atopic dermatitis

Atopix Therapeutics Ltd, a biopharmaceutical company developing a novel class of anti-allergic medicines, has been awarded a £1.7 million grant from the UK Biomedical Catalyst fund to pursue development of OC459 in the treatment of moderate-to-severe atopic dermatitis (a form of eczema).

29 May 2013

Consumption of illegal drugs, abusive intake of soda can damage teeth

Addicted to soda? You may be shocked to learn that drinking large quantities of your favorite carbonated soda could be as damaging to your teeth as methamphetamine and crack cocaine use.

29 May 2013

Alkermes reports positive results from phase 1 study of ALKS 3831 for treatment of schizophrenia

Alkermes plc today presented positive results from a phase 1 study of ALKS 3831, a novel drug candidate for the treatment of schizophrenia, in an oral session at the 53rd Annual New Clinical Drug Evaluation Unit Meeting in Hollywood, Fla.

28 May 2013

New equations could shorten hospitalization for patients with uncontrolled pain, say researchers

For patients with uncontrolled pain from terminal cancer, a new approach to calculating initial dosage may allow a quicker start of spinal analgesia-and less time in the hospital, according to a study in the June issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

28 May 2013

Unintentional ingestions of marijuana-laced foods by children have increased significantly

A new study shows the relaxation of marijuana laws in Colorado has caused a significant spike in the number of young children treated for accidentally eating marijuana-laced cookies, candies, brownies and beverages.

28 May 2013

Preventive dental visits for kids linked to more expensive restorative procedures

It may seem logical that taking children to the dentist for regular preventive check-ups will lead to fewer pricy restorative procedures like filling a cavity. But new findings from the University of Alabama at Birmingham (UAB) published online in Pediatrics show the opposite.

28 May 2013

Astellas submits application for marketing approval of enzalutamide for prostate cancer

Astellas Pharma Inc. and Medivation, Inc. today announced that Astellas has submitted an application for marketing approval of enzalutamide (generic name) to the Ministry of Health, Labour and Welfare in Japan for the treatment of prostate cancer.

24 May 2013

Takeda begins MLN9708 phase 3 clinical trial in newly diagnosed myeloma patients

Takeda Pharmaceutical Company Limited today announced the initiation of an international phase 3 clinical trial evaluating once a week MLN9708 in combination with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma who are not candidates for transplant.

24 May 2013

Spring Bank Pharmaceuticals starts Phase I study of SB 9200 for treatment of HCV infection

Spring Bank Pharmaceuticals, Inc., a biopharmaceutical company developing innovative medicines for the treatment of viral infections, today announced that it has initiated dosing in a Phase I study of SB 9200, its investigational, once daily, oral therapy for the treatment of HCV infection.

24 May 2013

FDA approves Tina-quant HbA1cDx assay for diagnosis of diabetes

Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay) for the diagnosis of diabetes by health care professionals.

24 May 2013

Market pressures may keep premiums low as health law kicks in

USA Today reports this optimisitic view is offered by some industry analysts and health insurance officials. Meanwhile, Politico does a status check on the legal challenges to the health law's birth control mandate. News reports also track the latest regarding the Internal Revenue Service controversy and the overhaul.

23 May 2013

Research finds number of links between dental health and overall health

If the eyes are the windows to your soul, then your mouth is the gateway to your overall health. Research has found a surprising number of links between the state of your dental health and your overall health.

23 May 2013

AASLD members at forefront to raise awareness of hepatitis B and C

Viral hepatitis is an asymptomatic disease affecting more than 5.3 million Americans. More than 75 percent of those with hepatitis C are unaware they have the virus.

23 May 2013

GUVAX reports successful results in phase I study of oral, Escherichia coli diarrhea vaccine

The University of Gothenburg Vaccine Research Institute (GUVAX) announces successful results in a placebo controlled phase I study of an oral, inactivated Escherichia coli diarrhea vaccine.

22 May 2013

First Edition: May 22, 2013

Today's headlines include reports about how the Medicaid expansion is shaking out in Virginia and Texas, as well as a report about the role health care is playing as the House attempts to negotiate an immigration reform measure.

22 May 2013

Study reinforces efficacy of NeuroStar TMS Therapy System in patients with MDD

New data released today at the annual meeting of the American Psychiatric Association show that the NeuroStar TMS Therapy System induced statistically and clinically meaningful response and remission in patients with Major Depressive Disorder during the acute phase of therapy, which were maintained through one year of treatment.

22 May 2013

AIR2 trial: Alair BT System shows therapy benefits in adults with severe uncontrolled asthma

Five-year data from the Asthma Intervention Research 2 clinical trial presented today demonstrated that the Boston Scientific Corporation Alair Bronchial Thermoplasty System continues to show therapy benefits in adult patients with severe uncontrolled asthma.

22 May 2013

Gilead Sciences' sofosbuvir MAA gets EMA validation

Gilead Sciences, Inc. today announced that the company's Marketing Authorisation Application for sofosbuvir, a once-daily oral nucleotide analogue inhibitor for the treatment of chronic hepatitis C virus infection, which was submitted to the European Medicines Agency on April 17, 2013, has been fully validated and is now under assessment.

22 May 2013

Oral News and Research

Radiotherapy: First choice treatment for low-grade glioma

New article reports on global burden of oral conditions

Atopix awarded grant to pursue development of OC459 for atopic dermatitis

Consumption of illegal drugs, abusive intake of soda can damage teeth

Alkermes reports positive results from phase 1 study of ALKS 3831 for treatment of schizophrenia

New equations could shorten hospitalization for patients with uncontrolled pain, say researchers

Unintentional ingestions of marijuana-laced foods by children have increased significantly

Preventive dental visits for kids linked to more expensive restorative procedures

Astellas submits application for marketing approval of enzalutamide for prostate cancer

Takeda begins MLN9708 phase 3 clinical trial in newly diagnosed myeloma patients

Spring Bank Pharmaceuticals starts Phase I study of SB 9200 for treatment of HCV infection

FDA approves Tina-quant HbA1cDx assay for diagnosis of diabetes

Market pressures may keep premiums low as health law kicks in

Research finds number of links between dental health and overall health

AASLD members at forefront to raise awareness of hepatitis B and C

GUVAX reports successful results in phase I study of oral, Escherichia coli diarrhea vaccine

First Edition: May 22, 2013

Study reinforces efficacy of NeuroStar TMS Therapy System in patients with MDD

AIR2 trial: Alair BT System shows therapy benefits in adults with severe uncontrolled asthma

Gilead Sciences' sofosbuvir MAA gets EMA validation

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News